Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Antibodies
Filter     Order     Display # 
Date Item Title
03 Jul 2008 Phase III ARISER study with RENCAREX(R): patient recruitment successfully completed
02 Jul 2008 Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
01 Jul 2008 UCB's Cimzia(R) filed with EMEA for treatment of rheumatoid arthritis
30 Jun 2008 Takeda Submitted a New Drug Application for Anti-Cancer Agent, panitumumab (recombinant)
29 Jun 2008 Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
29 Jun 2008 New Data Show Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Vectibix(R) (Panitumumab)
25 Jun 2008 CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
25 Jun 2008 IMC-A12 Plus Temsirolimus Clinical Trial for Advanced Cancer Opens for Patient Enrollment
25 Jun 2008 Genmab Initiates Study of Zalutumumab with Radiotherapy in Head and Neck Cancer
24 Jun 2008 Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
19 Jun 2008 Merck Applies to Extend Use of Erbitux for First-Line Head and Neck Cancer in Europe
19 Jun 2008 Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
18 Jun 2008 ThromboGenics and BioInvent announce a strategic alliance with Roche for TB-403, a novel anti-cancer antibody
18 Jun 2008 Biotie's VAP-1 Antibody Program to Proceed to Clinical Studies in Rheumatoid Arthritis and Psoriasis Patients
18 Jun 2008 FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
17 Jun 2008 Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
17 Jun 2008 Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
16 Jun 2008 Romiplostim Data Show Potential Long-Term Efficacy and Safety in Adults with Chronic ITP
16 Jun 2008 OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
15 Jun 2008 New data reveals Actemra is the first and only biologic drug to show superiority over current standard of care in rheumatoid arthritis
15 Jun 2008 Data from Phase II Exploratory Study Suggest That ORENCIA(R) (abatacept) May Delay Development of Rheumatoid Arthritis in Adults with Undifferentiated Inflammatory Arthritis
15 Jun 2008 New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
15 Jun 2008 Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
15 Jun 2008 HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis with Combination Treatment Resulted in Cost Savings From Improved Work Productivity
12 Jun 2008 ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis
12 Jun 2008 Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11 Jun 2008 Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
11 Jun 2008 Ofatumumab in subcutaneous study in rheumatoid arthritis
10 Jun 2008 Symphogen Enters into strategic collaboration with Genentech for antibody thera-peutics
09 Jun 2008 XOMA 052 Demonstrates Anti-Inflammatory Effect in Arthritis Animal Studies; Data Presented At FOCIS
09 Jun 2008 Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
08 Jun 2008 WILEX and IBA enter into worldwide marketing, distribution and sales agreement on REDECTANE(R) (CA9-SCAN)
05 Jun 2008 Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma
05 Jun 2008 Merck Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
05 Jun 2008 Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
05 Jun 2008 Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma
04 Jun 2008 ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Findings with Trastuzumab-DM1 at ASCO
04 Jun 2008 Seattle Genetics Reports Multiple Complete and Partial Responses with SGN-35 in Patients with Lymphoma
04 Jun 2008 BioInvent and ThromboGenics report positive Phase I results for anti-PlGF cancer therapeutic TB-403
04 Jun 2008 Bradmer Receives FDA Approval to Proceed with Phase III Clinical Trial
03 Jun 2008 Seattle Genetics Announces Initiation of SGN-40 Phase Ib Clinical Trial in Combination With Velcade for Multiple Myeloma
03 Jun 2008 Trubion Announces Presentation of Positive TRU-016 Data at ASCO
03 Jun 2008 New Pfizer Data Presented on CP-751,871 across Non-Small Cell Lung Cancer and Ewing’s Sarcoma
03 Jun 2008 Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
03 Jun 2008 Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
02 Jun 2008 Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer
02 Jun 2008 ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
02 Jun 2008 New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting
02 Jun 2008 Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 998

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Integrin Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonistgs & Antagonists

Order Now

Subscribe La Merie Biologics